Difficult‐to‐treat patients with relapsed/refractory multiple myeloma: A review of clinical trial results

Overall outcomes for multiple myeloma have improved due to the availability of new therapies, but patients with relapsed/refractory multiple myeloma harbouring certain factors continue to pose a therapeutic challenge. These challenging features include high‐risk cytogenetics, renal impairment, patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Raab, Marc S., Zamagni, Elena, Manier, Salomon, Rodriguez‐Otero, Paula, Schjesvold, Fredrik, Broijl, Annemiek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10660429/
https://www.ncbi.nlm.nih.gov/pubmed/38024633
http://dx.doi.org/10.1002/jha2.743

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10660429/
https://www.ncbi.nlm.nih.gov/pubmed/38024633
http://dx.doi.org/10.1002/jha2.743

Ejemplares similares